Unique ID issued by UMIN | UMIN000023130 |
---|---|
Receipt number | R000026033 |
Scientific Title | Lymph node metastasis detection by OSNA in colon cancer: A prospective multicenter trial in Japan |
Date of disclosure of the study information | 2016/07/15 |
Last modified on | 2016/07/19 17:30:51 |
Lymph node metastasis detection by OSNA in colon cancer: A prospective multicenter trial in Japan
Lymph node metastasis detection by OSNA in colon cancer: A prospective multicenter trial in Japan
Lymph node metastasis detection by OSNA in colon cancer: A prospective multicenter trial in Japan
Lymph node metastasis detection by OSNA in colon cancer: A prospective multicenter trial in Japan
Japan |
Colorectal cancer
Gastrointestinal surgery |
Malignancy
NO
To examine the clinical stage when OSNA examination result is added to the standard pathological one.
Efficacy
Exploratory
Phase IV
To seek proportion of cases which are OSNA examination positive and pathological examination negative.
To find out predictive factors of metastasis.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1. Be diagnosed with colorectal cancer including colon cancer and/or rectal cancer, clinically staged No or N1. Limited to Ra and Rs in rectal cancer.
2. Signed informed consent.
1. who lack the capacity to consent.
2. Who receives/received preoperative chemotherapy.
3. Who is diagnosed with Rb.
4. Active double cancer.
5. who attending physicians consider to be inappropriate due to other reasons m
225
1st name | |
Middle name | |
Last name | Nariaki Matsuura, M.D., Ph.D. |
Osaka Medical Center for Cancer and Cardiovascular Diseases
President
3-3 Nakamichi 1-Chome, Higashinari-ku, Osaka, 537-8511 Japan
06-6972-1181
nmatsuura@mc.pref.osaka.jp
1st name | |
Middle name | |
Last name | Contact for Marketing |
Sysmex Corporation
Life Science Product Engineering
4-4-4 Takatsukadai, Nishiku, Kobe 651-2271, Japan
078-992-7055
lifescience@sysmex.co.jp
Osaka Medical Center for Cancer and Cardiovascular Diseases
Sysmex Corporation
Profit organization
Japan
NO
大分大学/Oita University
大阪大学医学部附属病院/Osaka University
大阪府立成人病センター/Osaka Medical Center for Cancer and Cardiovascular Diseases
関西ろうさい病院/Kansai Rosai Hospital
札幌医科大学/Sapporo Medical Univeristy
市立吹田市民病院/Suita Municipal Hospital
駿河台日本大学病院/Surugadai Nihon University Hospital
東京女子医科大学/Tokyo Women’s Medical Univiersity
栃木県立がんセンター/Tochigi Cancer Center
兵庫医科大学病院/Hyogo College of Medicine
箕面市立病院/Minoh City Hospital
シスメックス株式会社/Sysmex Corporation
2016 | Year | 07 | Month | 15 | Day |
Published
http://www.ncbi.nlm.nih.gov/pubmed/26438440
The concordance rate between 1 slice hematoxylin/eosin and OSNA assay was 95.7 % (1,842/1925 lymph nodes). The sensitivity and specificity of the OSNA assay were 86.2 % (125/145) and 96.5 % (1717/1780), respectively. Among 124 node-negative patients (pN0), the respective upstaging rates of pStages I, IIA, IIB, and IIC were 2.0 % (1/50), 17.7 % (11/62), 12.5 % (1/8), and 25 % (1/4). OSNA-positive patients had deeper invasion to the colonic wall and severe lymphatic invasion (P = 0.048 and P = 0.004, respectively).
Completed
2012 | Year | 02 | Month | 20 | Day |
2012 | Year | 04 | Month | 01 | Day |
2013 | Year | 08 | Month | 31 | Day |
2014 | Year | 03 | Month | 04 | Day |
2014 | Year | 06 | Month | 16 | Day |
2014 | Year | 07 | Month | 18 | Day |
Patient enrollment: patients from 11 institutes who met eligibility criteria of the study between the periods after IRB approval until August of 2013 were enrolled in the study.
2016 | Year | 07 | Month | 12 | Day |
2016 | Year | 07 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026033
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |